News
-
-
COMMUNIQUÉ DE PRESSE
Cherry SE: Successful Analyst and Investor Day; preliminary figures for Q1 2024 above own forecast and market expectations; outlook for the current year confirmed
Cherry SE exceeds Q1 2024 preliminary figures in successful Analyst and Investor Day, confirming positive outlook for the year. Find out more at https://ir.cherry.de/home/publications/#presentations-webcasts -
-
COMMUNIQUÉ DE PRESSE
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
Biotricity Inc. experiences high demand for Biotres Pro - a revolutionary medical device expected to raise revenue by 10% in fiscal 2025. The device with premium features attracts existing and new customers -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Linde Increases Production Capacity and Reduces Emissions in Florida
Linde increases production capacity by 50% at its Mims facility in Florida to meet growing demand for industrial gases. The expansion also aims to reduce emissions through participation in SolarTogether® program -
COMMUNIQUÉ DE PRESSE
CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth
CHEPLAPHARM reports record revenue of €1.5 billion and 17% year-over-year growth in financial year 2023. EBITDA up 14% to €780.5 million with stable 52% margin. Expansion with new affiliates in Japan and Switzerland
